Semax 5mg
Size: 5mg | 99% Purity
nM.Wt: 813.93
nFormula: C37H51N9O10S
nSolubility: H2O
nPurity: >99%
nStorage: -20°C / 3 years
nHalf life: Not established
nCAS No.: 80714-61-0
n
| Purity (HPLC) | >99% |
|---|---|
| Molecular weight | 813.93 g/mol |
| Molecular formula | C37H51N9O10S |
| CAS number | 80714-61-0 |
| Synonyms | Semax, ACTH(4-7)PGP, Met-Glu-His-Phe-Pro-Gly-Pro |
| Solubility | H2O |
| Storage | '-20°C / 3 years |
Peptide sequence
Met-Glu-His-Phe-Pro-Gly-Pro
Research reference: View mechanism, literature and identifier graph →
Reconstitution calculator (pre-filled for 5 mg)
Back-in-stock notification
Out of stock. Leave your email and we will notify you when it returns.
HPLC and MS verified by UKAS-accredited laboratories.
Free on orders over £50. Next-day upgrade available.
COA and batch number on every vial.
Semax 5mg — research reference material
n
Semax 5mg is supplied by ADIPHEX as a research reference material in a 5mg presentation. Compound class: Synthetic ACTH(4-7)-PGP heptapeptide, characterised in the literature as a nootropic neuropeptide. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
n
Research context
n
Nootropic peptide; studied in cognition, neuroprotection. Full mechanism detail, the identifier graph and selected peer-reviewed literature are set out on our Semax research reference. Related compounds in the same research area: Selank, DSIP. You can also compare it side by side on our comparison tool.
n
Presentation
n
This listing is the 5mg presentation at >99% stated purity, catalogue reference SX10.
n
Identifiers
n
- n
- CAS number: 80714-61-0
- Molecular formula: C37H51N9O10S
- Molecular weight: 813.93 g/mol
- Synonyms: Semax, ACTH(4-7)PGP, Met-Glu-His-Phe-Pro-Gly-Pro
- Class: Synthetic ACTH(4-7)-PGP heptapeptide
n
n
n
n
n
n
Format & quality
n
Supplied as 5mg at >99% purity. Identity and purity are characterised by reversed-phase HPLC and mass spectrometry, with a per-batch Certificate of Analysis available on request. This item is a lyophilised powder and requires reconstitution before use; bacteriostatic water is supplied separately, and our reconstitution guide covers volumes and concentrations. Solubility: H2O.
n
Storage
n
Store at -20°C, protected from light. Stated shelf life 3 years from date of manufacture. Always confirm against the Certificate of Analysis supplied with your batch.
n
Research use only — not for human or veterinary use, food, cosmetic or therapeutic application. ADIPHEX supplies this item as a laboratory reference material; no dosing or administration guidance is provided.
n
Frequently asked questions
n
What is Semax 5mg?
n
Synthetic ACTH(4-7)-PGP heptapeptide. Nootropic peptide; studied in cognition, neuroprotection. ADIPHEX supplies it as a research reference material only.
n
What is the CAS number for Semax 5mg?
n
80714-61-0. Molecular formula C37H51N9O10S. Molecular weight 813.93 g/mol.
n
How should Semax 5mg be stored?
n
At -20°C, protected from light, with a stated shelf life of 3 years. The batch Certificate of Analysis is the controlling document.
n
Certificate of Analysis
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.
Liu R et al. · British journal of pharmacology · 2025
PubMed PMID 40692165 -
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF et al. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
PubMed PMID 41490200 -
Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats.
Glazova NY et al. · Neuropeptides · 2021
PubMed PMID 33418449
You may also need
Related compounds
